Newsroom

14.03.2019
Octapharma Group reports strong results for 2018

Reporting revenue of €1.8 billion and operating income of €346 millionGroup sales increased 4.5% com...

more

26.11.2018
Octapharma receives Swissmedic approval for fibryga® to treat congenital and acquired fibrinogen deficiencies

Lachen, Switzerland – 26 November 2018 – Octapharma today announced that the Swiss Agency for Therap...

more

Career

Octapharma’s success is the result of the combined contribution of all employees, what we call “the human factor”. To embark on a challenging and rewarding career in an innovative biopharmaceutical organization, explore our global opportunities 

Annual Report 2018